ECMO for Critically Ill Patients With Respiratory Failure and/or Circulatory Failure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-22

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Extracorporeal membrane oxygenation (ECMO) had been used to treat refractory hypoxemia associated with acute respiratory distress syndrome (ARDS). There were reported good outcome associated with ECMO for ARDS caused by influenza infection from several ECMO centers. However, the outcome of ECMO support in lower ECMO experience center had not been evaluated. This study aimed to evaluate the outcome of ECMO, comparing with conventional treatment among severe hypoxemic ARDS patients who were admitted in limited ECMO experience hospital.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

China Extracorporeal Life Support Registry

NCT04158479

Cardiogenic Shock Cardiac Arrest Heart Failure +2 more

RECRUITING

Extracorporeal Membrane Oxygenation for Respiratory Failure Patients

NCT06231446

Respiratory Failure Patients Treated With ECMO

RECRUITING

Establishment of a Early Risk Model of ECMO in Children With ARDS

NCT04710173

ARDS

COMPLETED

Extracorporeal Support for Respiratory Insufficiency (ECMO)

NCT00000562

Acute Respiratory Failure Lung Diseases

COMPLETED PHASE3

Clinical Studies of the Effects of Extracorporeal Membrane Oxygenation for Severe ARDS Mortality

NCT01677117

ECMO Treatment

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This registry enroll refractory hypoxemia ARDS patients who met the criteria for veno-venous ECMO, according to 2013 Extracorporeal Life Support Organization (ELSO) guideline criteria. The definition of refractory hypoxemia was partial pressure of oxygen:fraction of inspire oxygen (PaO2/FiO2) \<100 with fraction of inspire oxygen (FiO2) \>90% despite optimal mechanical ventilator support for at least 2 hours.

The ECMO team was alerted for patient evaluation. The patients, who did not consider as ECMO candidate, due to their underlying condition of terminally illness, were excluded.

The decision to initiate ECMO, or not, is dependent on the conference included the patient or the patient first relative, the attending physician and the ECMO team physicians.

Patients who ECMO is initiated will be classified into ECMO group. Patients who they or their 1st degree relative do not agree for ECMO initiation will be treated according to standard treatment for ARDS, and classified in non-ECMO group.

The patients in both groups will be follow up until they are discharged from the hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severe Acute Respiratory Distress Syndrome Refractory Hypoxemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional ARDS treatment group

Patients who they or their 1st degree relative refuse to initiate ECMO. They will receive conventional ARDS treatment.

No interventions assigned to this group

ECMO group

Patients who ECMO is initiated for treat refractory hypoxemia. They will receive conventional ARDS treatment and ECMO support

Extra Corporeal Membrane Oxygenator (ECMO)

Intervention Type DEVICE

Two cannular will be inserted via femoral vein or internal jugular vein and connect with blood pump and membrane oxygenation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Extra Corporeal Membrane Oxygenator (ECMO)

Two cannular will be inserted via femoral vein or internal jugular vein and connect with blood pump and membrane oxygenation.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed ARDS according to Berlin criteria
* Refractory hypoxemia: PaO2/FiO2 \<100 with FiO2 \>90% despite optimal mechanical ventilator support and paralytic agent infusion
* Hypoxemia persist for at least 2 hours